NeuroSense Therapeutics

NeuroSense Therapeutics is a company listed under the stock ticker NRSN (IL).

View the org chart displaying its 18 main executives

Most searched biographies at NeuroSense Therapeutics

• Alon Ben-Noon, Chief Executive Officer
• Cary Claiborne, Board Member
• Mark Leuchtenberger, Chairman of the board

Create your alert
to follow the executive moves at NeuroSense Therapeutics.

NeuroSense Therapeutics has 2,289 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).
• Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on May 13 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Vik Bajaj - Director at Interline Therapeutics

Learn more about the Biotechnology industry >

Press releases by NeuroSense Therapeutics

• Publications & News - Neurosense

Social media about NeuroSense Therapeutics

• NeuroSense Therapeutics on Wikipedia, Google News & Yahoo Finance
• NeuroSense Therapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Alon Ben-Noon

Call NeuroSense Therapeutics at +972 ...

View the org chart

Register to receive your alert

Report an error